High level expression of human MCP-1 using the LCR/MEL expression system.

Protein Expr Purif

Vascular, Inflammatory & Musculo-skeletal Research Department, ZENECA Pharmaceuticals, Macclesfield, Cheshire, United Kingdom.

Published: March 1996

We have expressed human monocyte chemoattractant protein-1 (hMCP-1) in preerythroid mouse erythroleukemia (MEL) C88 cells using the locus control region/MEL expression system and studied the biological activity of the purified protein in a range of in vitro experimental systems. The recombinant hMCP-1 is expressed at high levels (approximately 10 mg/liter) in this system and is modified in a manner which is very similar to native hMCP-1. We have developed a simple high-yielding two-step purification route employing dye ligand and ion exchange chromatographies which enables us to separate glycosylated and unglycosylated hMCP-1. The purified glycosylated and unglycosylated forms of hMCP-1 have equivalent biological activities in all of the assay systems tested.

Download full-text PDF

Source
http://dx.doi.org/10.1006/prep.1996.0025DOI Listing

Publication Analysis

Top Keywords

expression system
8
glycosylated unglycosylated
8
hmcp-1
5
high level
4
level expression
4
expression human
4
human mcp-1
4
mcp-1 lcr/mel
4
lcr/mel expression
4
system expressed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!